Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lenhoff

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|January 11, 2007
Cytogenetic evolution patterns in CML post-SCTK Karrman, B Sallerfors, S Lenhoff, et al.
British Journal of Haematology|January 14, 1999
Clinical utility of immunoglobulin heavy chain gene rearrangement identification for tumour cell detection in multiple myelomaA Swedin, S Lenhoff, T Olofsson, et al.
British Journal of Haematology|June 10, 2000
Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myelomaG Juliusson, F Celsing, I Turesson, et al.
European Journal of Haematology|June 26, 2001
Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myelomaN Gulbrandsen, F Wisløff, E Nord, et al.
Annals of the Rheumatic Diseases|September 1, 1996
Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donorG Sturfelt, S Lenhoff, B Sallerfors, et al.
European Journal of Haematology|January 1, 1996
NRAS mutations are rare in acute myeloid leukaemias with t(8;21) or inv(16)I Panagopoulos, P Aman, B Johansson, et al.
Bone Marrow Transplantation|January 13, 2004
Autologous del(20q)-positive erythroid progenitor cells, re-emerging after DLI treatment of an MDS patient relapsing after allo-SCT, can provide a normal peripheral red blood cell countJ H Dykes, A Lindmark, S Lenhoff, et al.
European Journal of Haematology|September 13, 2002
Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulationT Nilsson, S Lenhoff, I Turesson, et al.
Cytotherapy|April 28, 2006
Quality assessment of autografting by probability evaluation: model estimation by clinical end-points in newly diagnosed multiple myeloma patientsO Roer, J Hammerstrøm, S Lenhoff, et al.
Bone Marrow Transplantation|October 4, 2016
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009S Rosengren, U-H Mellqvist, H Nahi, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|January 11, 2007
Cytogenetic evolution patterns in CML post-SCTK Karrman, B Sallerfors, S Lenhoff, et al.
British Journal of Haematology|January 14, 1999
Clinical utility of immunoglobulin heavy chain gene rearrangement identification for tumour cell detection in multiple myelomaA Swedin, S Lenhoff, T Olofsson, et al.
British Journal of Haematology|June 10, 2000
Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myelomaG Juliusson, F Celsing, I Turesson, et al.
European Journal of Haematology|June 26, 2001
Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myelomaN Gulbrandsen, F Wisløff, E Nord, et al.
Annals of the Rheumatic Diseases|September 1, 1996
Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donorG Sturfelt, S Lenhoff, B Sallerfors, et al.
European Journal of Haematology|January 1, 1996
NRAS mutations are rare in acute myeloid leukaemias with t(8;21) or inv(16)I Panagopoulos, P Aman, B Johansson, et al.
Bone Marrow Transplantation|January 13, 2004
Autologous del(20q)-positive erythroid progenitor cells, re-emerging after DLI treatment of an MDS patient relapsing after allo-SCT, can provide a normal peripheral red blood cell countJ H Dykes, A Lindmark, S Lenhoff, et al.
European Journal of Haematology|September 13, 2002
Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulationT Nilsson, S Lenhoff, I Turesson, et al.
Cytotherapy|April 28, 2006
Quality assessment of autografting by probability evaluation: model estimation by clinical end-points in newly diagnosed multiple myeloma patientsO Roer, J Hammerstrøm, S Lenhoff, et al.
Bone Marrow Transplantation|October 4, 2016
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009S Rosengren, U-H Mellqvist, H Nahi, et al.
Pageof 4